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Abstract: The aim of this study was to investigate the wound healing activity of 
atranorin cream (Patent requested) on excision wounds. Seventy-two male rats were 
anesthetized and an excisional wound was performed. Then the rats were randomly 
assigned into three groups: untreated control group; atranorin 1 (group treated with 
1% AT ointment); and atranorin 5 (group treated with 5% AT ointment). Six animals 
of each group were euthanized 3, 7, 14 or 21 days after surgical procedures and the 
wounded areas were analyzed and removed. Serial histological sections were obtained 
and stained by histochemical techniques (Hematoxilin-Eosin-HEand Sirius red) and 
immunohistochemical techniques. Topical application of atranorin reduced wound 
areas, induced earlier granulation tissue formation, increased cell proliferation, 
improved collagenization and modulated the myofi broblasts differentiation when 
compared to control animals. It is suggested that atranorin modulates the wound 
healing process. These data suggest that this formulation based on atranorin extracted 
from Cladina kalbii AHTI may be a new biotechnological product for wound healing 
clinical applications.
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Introduction
 Dermal wound healing is a complex phenomenon 
characterized by a sequence of independent and overlapped 
events described as exsudative/infl ammatory, proliferative 
(granulation tissue formation and collagen synthesis) and 
remodeling phases (Diegelmann & Evans, 2004). The 
analysis of the kinetic of these biological events in response 
to novel pharmacological substances is important for the 
development of effi cient therapeutic products capable of 
stimulating the wound healing (Alborova et al., 2007).
 Lichens are symbiotic organisms composed of a 
fungus and an alga. They produce characteristic secondary 
metabolites “lichen substances” that seldom occur in 
other organisms. Lichens and their metabolites have many 
biological activities such as antimicrobial (Rankovic et 
al., 2008), antiviral (Huneck, 1999), antioxidant (Behera 
et al., 2008), wound healing (Nunes et al., 2011), anti-
infl ammatory (Vijayakumar et al., 2000) and analgesic 
activity (Maia et al., 2002; Siqueira et al., 2010).
 In the Brazilian northeastern area, there is a 
variation of occurrence of lichen species according to the 
shift from the coastal zone (humid), to the inner part of 
the country, where the climate is semi-arid (an ecosystem 
known as “caatinga”). In these habitats several lichen 
species were mentioned to be bioactive (Maia et al., 2002). 
Atranorin (AT), an important lichen metabolite, has been 
utilized for medicinal, perfumery, cosmetic as well as 
ecological applications (Ingólfsdóttir, 2002). 
 Some studies show biological activities such as 
antimicrobial (Rankovic et al., 2008), antioxidant (Toledo 
et al., 2003) and elastase inhibitor (Proksa et al., 1994). In 
addition, recent studies suggest a possible antinociceptive 
effect of AT in unspecifi c tests (Melo et al., 2008) and shows 
that AT inhibits COX-1 and COX-2 in a dose-dependent 
manner (Bugni et al., 2009). Additional studies on AT 
demonstrated that it effectively inhibits the biosynthesis of 
leukotriene B4 in bovine polymorphonuclear leukocytes, 
which could also lead to an anti-infl ammatory effect 
(Kumar & Müller, 1999).
 Despite many pharmacological properties 
involved in the dynamics of the healing process have been 
related to AT, there is no report regarding to the effects 
of this lichenic product on in vivo dermal wound healing. 
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Therefore, the aim of the present study was to investigate the 
wound healing activity of cream of AT (Patent requested, 
PI1003289-4; Quintans-Júnior et al., 2012) extracted from 
Cladina kalbii (DES ABB.) Ahti on excision wounds in 
rats.
Material and Methods 
Lichen material and extraction and isolation of atranorin
 Cladina kalbii was collected in March 2007 in 
the Itabaiana County, Sergipe State, northeastern Brazil 
(10°44’S, 37°23’W). Cladina kalbii was identified by M. 
P. Marcelli (Botanical Institute of São Paulo-SP, Brazil) 
and herbarium voucher specimens (registry number SP 
393235) were prepared and deposited at the Botanical 
Institute of São Paulo-SP, Brazil. Atranorin was isolated 
from Cladina kalbiias previously described (Melo et al., 
2008) and stored at -20 ºC.
Animal assays 
 Male Wistar rats (220-260 g) were used for all 
experiments. Animals were housed under conditions of 
controlled temperature (25±1 ºC) and lighting (lights on: 
6 am to 6 pm) and had free access to food and water. All 
procedures described in the present work were approved 
by the Animal Research Ethics Committee of the Federal 
University of Sergipe (CEPA/UFS # 55/07) and were 
in compliance with the Guide for the Care and Use 
of Laboratory Animals published by the US National 
Institutes of Health (NIH Publication 85-23, revised 1996; 
http://www.nap.edu/readingroom/books/labrats/index.
html).
Surgical procedures
 Seventy-two rats were anesthetized with 
thiopental (40 mg/kg, i.p.) (Wua et al., 2012) and one full-
thickness excisional wound was performed using a 8 mm 
biopsy punch on the back (in the middle, on the spine, 1 cm 
under the interescapular area) of each animal (Freitas et al., 
2010). The animals were handled in accordance with aseptic 
principles to avoid exogenous bacterial contamination. 
Then the rats were randomly assigned into three groups 
of 24 animals each: CTR (control group or group treated 
with base ointment-30% lanoline and 70%vaseline); AT1 
(group treated with 1% atranorin ointment); and AT5 
(group treated with 5% atranorin ointment). All animals 
were treated immediately after the surgical procedure. A 
single administration of the ointment (0.1 g, base, with 
either 1% or 5% atranorin) was daily performed using 
hands and a spatula till 24 h prior to the euthanasia. 
Following the daily administration of the ointment, 
the animals had their wounds covered by healings. Six 
animals of each group were euthanized by administration 
of thiopental (150 mg/mL, i.p.) on 3rd, 7th, 14th or 21st day 
after the surgical procedures and the wounded areas were 
removed and fixed in a 10% formaldehyde solution. The 
surgical specimens were paraffin-embedded according 
to the routine laboratorial techniques. Histological 
sections, serial, of 5 μm thick, were obtained and stained 
by histochemical and immunohistochemical techniques. 
Thereafter, the histological analysis of the wounds was 
carried out as detailed hereafter.
Macroscopic analysis and wound contraction
 The clinical features of wounds were monitored 
regarding to the presence of crust, secretion, necrosis 
and hypertrophic scars. Craniocaudal and latero-lateral 
measures of each wound were assessed by using a digital 
caliper and the final wound areas were obtained thorugh 
the equation A=π.R.r/2, where A represents the area; π, a 
mathematical value was used until the 4th number after the 
decimal point, which corresponds to 3.1415; R represents 
the craniocaudal axis and r corresponds to the latero-lateral 
axis of the wounds. 
Histological analysis
 All the histological analyses were performed 
by two observers blinded to the treatment. Sections 
stained in HE were analyzed under conventional light 
microscope to assess the inflammatory response (IR) 
and epithelization rates (ER). IR was determined by 
classifying the inflammatory infiltrate according to the 
predominant leukocyte subset as acute (predominance of 
polymorphonuclear cells/neutrophils), subacute (balance in 
the content of polymorphonuclear and mononuclear cells) 
or chronic (predominance of mononuclear cells), and then 
graded considering the intensity of the infiltrate as mild/
absent (+), moderate (++) or severe (+++), as previously 
described by Ribeiro et al. (2009). ER were evaluated 
by measuring the lengths of the epidermal tongues from 
both wound edges in a microscope with a ruler, and data 
were expressed as percentage wound closure (distance of 
migrated keratinocytes from the wound edge/total wound 
width x 100). 
 Collagen content was analyzed in the Picrosirius-
stained sections, assessed under the ordinary polychromatic 
and polarized light microscopies. The proportion of 
tissue stained with picrosirus red content was assessed 
by descriptive analysis. Collagen fibers were analyzed 
according to their birefringence pattern (greenish/yellow-
greenish or orange/orange-reddish), morphological 
appearance (wavy or stretched, thin or thick, short or 
long) and architectural arrangement (reticular, parallel or 
interlaced).
 The quantitative analysis of the content 
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of collagen fibers deposition (CF) in the healing 
area was determined by optical density in the image 
analysis system in different randomly selected fields. 
The system used consists of a CCD Sony DXC-101 
camera, applied to a Olympus CX31 microscope, from 
which the images were sent to a monitor (Trinitron 
Sony). By means of a digitizing system (Olympus 
C-7070 WIDEZOOM) the images were inserted into 
a computer (Pentium 133 MHz), and processed by a 
software (ImageTool). A total of ten fields per case were 
analyzed at a magnification of 100x. The thresholds 
for collagen fibers were established for each slide, 
after enhancing the contrast up to a point at which the 
fibers were easily identified as birrefringent (collagen) 
bands. The area occupied by the fibers was determined 
by digital densitometric recognition, by adjusting the 
threshold level of measurement up to the different color 
densities of the collagen fibers. The area occupied by 
the fibers was divided by the total area of the field. The 
results were expressed in percentage of the skin area 
fraction occupied by the collagen fibers.
Assessment of the mean of myofibroblasts for histological 
field (MF)
 Myofibroblasts were detected by using a 
monoclonal antibody against the α-smooth muscle 
actin antigen (clone 1A4; 1:200, 12 h, Dako, Glostrup, 
Denmark). After washing in PBS, slides were incubated 
with biotin-labeled antimouse secondary antibodies 
(Vector Laboratories Inc., Burlingame,CA), then washed 
in PBS, and incubated with peroxidase-labeled streptavidin 
(DAKO). The reaction products were visualized by 
immersing the slides in freshly prepared diaminobenzidine 
(Dojindo, Kumamoto, Japan). Ten histological sections 
(40x, 10 ocular, 0.739 mm2 per field) were randomly 
selected and the mean of immunostained cells was assessed 
with an image analysis system Imagelab® (Sof-tium, São 
Paulo, SP, Brasil) as previously described by Ribeiro et 
al. (2009). Only spindle-shaped and round cells scattered 
in the connective tissue we regarded as myofibroblasts 
(Ribeiro et al., 2009).
Statistical analysis
 The histological analysis of the intensity of the 
inflammatory infiltrate was analyzed by Kruskall-Wallis 
test, followed by Dunnett´s post-test. The epithelization 
rates and the mean of mast cells were compared among 
the groups by one-way analysis of variance (ANOVA) 
followed by Tukey´s post test p values less than 0.05 were 
regarded as statistically significant.
Results
Analysis of the wound area
 Topical application of both formulations based 
on atranorin decreased significantly the unhealed area on 
3rd and 7th day following the wound, whereas on the 14th 
day later only AT5 provided significant reduction of the 
wound area (Figure 1). Twenty-one days later there was no 
difference among the groups (Figure 1).
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Figure1. Effect of the atranorin on wound area of rats. Value 
represents the mean±SEM. *p<0.05 and **p<0.01 when 
compared to control group. ANOVA followed by Dunnett`s test 
(n=6, per group).
Histological analysis
 The intensity of the inflammatory response 
was severe in absolutely all cases of CTR, AT1 and AT5 
at the third day. Besides, the leukocyte infiltrate was 
predominantly composed of neutrophils, characterizing 
an acute inflammatory reaction (Figure 2 a/b/c). On 7th 
day, despite the intensity of the inflammatory response 
had been still severe in all groups, the leukocyte infiltrate 
was predominantly acute in CTR, subacute in AT1 (rich in 
both polymorphonuclear and mononuclear inflammatory 
cells) and chronic (lymphocyte and plasma cell-rich) in 
AT5 group. In addition, the development of a delicate 
network of slit capillary vessels forming an immature 
granulation tissue was observed in both atranorin-treated 
groups, although in the AT5 it had been observed a 
conspicuous fibroblastic content in association with the 
vascular component (Figure 2 d/e/f). At the 14th day, the 
intensity of the inflammatory response was predominantly 
moderate and the lymphocytes and plasma cells were the 
most abundant leukocyte infiltrate so that it was classified 
as nonspecific chronic infiltrate in all groups. A remarkable 
content of large spindle-shaped cells interpreted as active 
fibroblasts, mainly in the bottom of the healing area, was 
also observed, particularly in AT5 group (Figure 2 g/h/i). 
Moreover, only AT5 group presented the formation of 
epithelial buddings interpreted as cutaneous appendages 
rudiments in the epithelial lining (Figure 2i). Finally, at the 
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21st day, the inflammatory response was still regarded as 
moderate in both CTR and AT1 groups, but mild or absent 
in AT5 one. Plasma cells were the most abundant leukocyte 
infiltrate found in the connective tissue. Rudiments of 
cutaneous appendages were frequently found in CTR and 
AT1 groups, whereas in AT5 well-formed hairy follicles 
and sebaceous glands were observed within the collagenous 
scar (Figure 2 j/k/l).
 As indicated in the Figure 3, epithelization was 
inconspicuous until the seventh day after surgery. The 
epithelization rates were significantly higher in AT1 
(94.68%, p<0.05) and AT5 (98.8%, p<0.01) at the 14th day 
after surgery, but there was no difference among groups on 
3rd, 7th and 21st day. 
 Regarding to the collagenization, only scant 
deposition of thin delicate reticularly arranged fibrils 
exhibiting greenish and yellow-greenish birefringence 
(type-III collagen) was observed in all groups three days 
following surgery. However, in AT1 and AT5 groups, the 
fibers appeared thicker and longer than in CTR (Figure 4 
a/b/c). On the 7th day, there was remarkable improvement 
in the collagen fibers content, with clear reduction of the 
interfibrillary spaces, in AT1 and AT5 compared with 
CTR group. However, the newly formed fibrils sustained 
the yellow-greenish birefringence (type-III collagen 
molecules) and the reticular arrangement (Figure 4 d/e/f). 
Figure 2. Effect of the atranorin on microscopic analysis of wounds in rats.Acute inflammation seen in CTR (d), subacute 
inflammation seen in AT1 (e) and chronic in AT5 (f) at the 7th day. Remarkable content of large spindle-shaped cells interpreted 
as active fibroblasts, mainly in the bottom of the healing area and formation of epithelial buddings interpreted as cutaneous 
appendages rudiments in the epithelial lining in AT5 (i). Moderate inflammatory response in CTR and AT1, but mild or absent 
in AT5 at the 21st day (j, k and l).
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At the 14th day, there was a clear replacement of the delicate 
type-III collagen fibrils for gross and denser disposed 
type-I collagen fibers exhibiting orange birefringence. 
However, the content of collagen fibers was pointedly less 
conspicuous in CTR than in the other groups. Furthermore, 
despite AT1 and AT5 groups had presented high levels 
of collagenization, the pattern of the fibers arrangement 
observed in AT1 was predominantly parallel whereas in 
AT5 it was interlaced (Figure 4 g/h/i). Finally, at 21st day, 
CTR group presented intense deposition of gross thick 
parallel-arranged of both type I and III collagen bundles, 
less densely deposited in top of scars. The AT5 group 
showed the same mix of wavy and highly interlaced type 
I and type III collagen fibers, but the fibers seemed to be 
thinner and exhibited a dense interlaced arrangement that 
resembled the normal dermis (Figure 4 j/k/l). 
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Figure 3. Effect of the atranorin in epithelization rates of excision 
wounds of rats. Value represents the mean±SEM. *p<0.05 and 
**p<0.01 when compared to control group. ANOVA followed by 
Dunnett`s test (n=6, per group).
Figure 4. Effect of the atranorin on microscopic analysis of wounds in rats. Remarkable improvement in the collagen fibers, 
with clear reduction of the interfibrillary spaces, in AT1 and AT5 at the 7th day (e and f). High levels of collagenization with 
pattern of the fibers in parallel arrangement in AT1 (h) and interlaced in AT5 (i). Same mix of wavy and highly interlaced 
type I and type III collagen fibers, with the fibers less thick and exhibited a dense interlaced arrangement that resembled the 
normal dermis (l). 
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 As described in Figure 5, the quantitative 
analysis of the collagen deposition revealed that AT5, but 
not AT1, induced significantly more expressive deposition 
of collagen fibers in 7 (p=0.02) and 14 days (p=0.000). 
However, no difference among the groups was observed in 
3 (p=0.93) and 21 days (p=0.64).
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Figure 5. Effect of the atranorin in collagen fibers deposition 
of excision wounds of rats. Value represents the mean±SEM. 
*p<0.05, **p<0.01 and ***p<0.001 when compared to control 
group. ANOVA followed by Dunnett`s test (n=6, per group).
 Regarding the MF, Α-SM positive myofibroblasts 
were seen as brown spindle-shaped cells scaterred in 
the connective tissue. On the 3rd day, the myofibroblasts 
content was significantly lower in AT5 than in CTR 
(p<0.001). No significant difference was verified among 
the groups at the 7th day (p=0.058).On the 14th day, the 
content of myofibroblasts was significantly higher in CTR 
than in AT1 and AT5 (p<0.05 and p<0.01, respectively). 
However on 21st day, the myofibroblasts content was 
significantly higher in AT1 compared to CTR (p<0.001) 
and AT5 (p<0.001) (Figure 6).
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Figure 6. Effect of the atranorin in myofibroblasts content 
of excision wounds of rats. Value represents the mean±SEM. 
*p<0.05, **p<0.01 and ***p<0.001 when compared to control 
group. ANOVA followed by Dunnett`s test (n=6, per group).
Discussion
 The present study demonstrates a novel substance 
with an important role on wound healing. In this work, we 
evaluated the skin wound healing process after excision 
that had been treated with different doses of atranorin, a 
natural product extracted from Cladina kalbii. Our results 
showed that atranorin-treated animals presented reduced 
wound areas, earlier granulation tissue formation, higher 
cell proliferation and improved collagenization when 
compared to control animals. 
 During the healing process, the inflammatory 
response should occur rapidly to permit the development 
of subsequent phases of wound healing. Therefore, 
despite inflammatory response is absolutely required to 
provide wound healing, its long-term persistence has 
been considered one of the most important reasons for the 
delay of healing process (Clark, 1996). The severe acute 
inflammatory reaction observed in all the three groups 
on the 3rd day was expected, since soon after injury, as a 
result of vascular and biochemical changes, a substantial 
amount of neutrophils migrate into the wound to prevent 
the invasion and proliferation of microorganisms (Harlan, 
1985). However, atranorin administration seems to reduce 
the content of neutrophils in the wound area of rats treated 
at the 7th day when compared to control rats, facilitating 
the installation of the chronic inflammatory phase. The 
positive effect of atranorin on the inflammatory response 
might be related to the atranorin-induced inhibition of 
cycloxygenase (COX-1 and COX-2) activity (Bugni et 
al., 2009) and blockade of the biosynthesis of leukotriene 
B4 (Kumar & Müller, 1999), which could lead to 
an antiinflammatory effect. Atranorin also presented 
antibacterial and antioxidant properties, which could 
also contribute to reduce the chemotatic signalizing, 
and consequently the neutrophilic influx into the injured 
area (Mahmood et al., 2005). Moreover, the fact that the 
reduction of the neutrophilic infiltrate was more expressive 
in AT5 than in AT1 group may suggest that the biological 
effect of this product on the acute inflammatory response 
is dose-dependent. Notwithstanding, further studies are 
demanded to ratify this possibility.
 The similar inflammatory response among groups 
on the 14th and 21st day was expected, since in this periods 
the latter events of the healing process, such as fibroblastic 
proliferation and collagen synthesis, had already installed 
as a result of progressive decrease in the chemotactic 
stimuli and consequent reduction in the leukocytic infiltrate 
characteristic of the natural course of the healing process 
(Boyle et al., 1987).
 Epithelization is a process of restoring the 
epidermis and involves proliferation and migration 
of keratinocytes (Li et al., 2007). As keratinocytes 
are supposed to be a source of a variety of cytokines 
involved in remodeling the collagen fibers deposited at 
the final stages of the cicatricial repair, the development 
of epithelial lining is considered a relevant step of wound 
healing (Balasubramanian & Eckert, 2007). Furthermore, 
the epithelial bridge is also responsible for the removal of 
scab by dissolution of its attachments to the underlying 
connective tissue (Diegelmann & Evans, 2004).In this 
study, atranorin administration seemed to improve the 
epithelization during the complete experimental period, 
although only on the 14th day this improvement had 
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shown to be significant. Surprisingly, previous studies 
have reported that atranorin presented no effect on the 
keratinocytes proliferation in vitro (Kumar & Müller, 
1999). 
 Nevertheless, it must be remembered that during 
the formation of the granulation tissue, a wide sort of 
soluble factors involved in the modulation of keratinocytes 
proliferation is released into the healing area, including 
PDGF (Greenhalgh et al., 1990), TGF-β1 (Roberts 
et al., 1986), EGF (Buckley et al., 1985), and others 
(Cross & Mustoe, 2003). Therefore, as long as atranorin 
administration accelerated the granulation tissue formation, 
the histological findings regarding the epithelization might 
result of indirect effects associated to such growth factors. 
Although other still unknown biological processes are 
likely to be involved in the epithelization observed in 
this study, the fact that the significant improvement had 
occurred between 7th and 14th day seems to reinforce the 
role played by the granulation tissue-associated growth 
factors, since this is the period for skin second-intention 
cicatricial repair in which the most substantial content of 
such soluble constituents is released into the wound healing 
area (Werner & Crose, 2003). It must be emphasized that 
previous studies have already demonstrated that a wide 
range of natural products can be applied to modulate the 
kinetics of epithelial cells growth, either down-regulating 
(Valacchi et al., 2009) or stimulating the keratinocyte 
proliferation (Nunes et al., 2011).
 In normal tissues, collagen fibers provide 
strength, integrity, and structure; therefore, when tissues 
are disrupted following an injury, collagen deposition 
is essential for replacing the lost tissue and restoring 
anatomical structure and function (Diegelmann & Evans, 
2004). A clear improvement in the content of collagen 
fibers in the atranorin-treated groups was verified in this 
study. However, the mechanisms responsible for this 
beneficial effect are unclear. It is possible that the role 
played by atranorin in the dynamics of collagenization may 
be related to an upregulation of nitric oxide synthesis. The 
administration of exogenous nitric oxide has been proved 
to improve fibroblasts proliferation and collagen synthesis 
in rodent model (Schaffer et al., 2007). Additionally, 
some lichen metabolites have been recently implied in the 
positive modulation of the nitric oxide release in mouse 
macrophages (Carlos et al., 2009). Thus, we speculate 
whether atranorin might upregulate the fibroblastic 
proliferation, deposition of collagen fibers, and wound 
contraction. However, further investigations are required 
to clarify this mechanism and prove this theory right.
 The deposition of delicate type-III collagen fibrils 
on 3rd and 7th day found in this study was expected, since 
these protein molecules are extensively required to provide 
spatial orientation to angioblasts migration in order to form 
the granulation tissue during the very early stages of wound 
healing (Ramos & Miranda, 2007). Once the granulation 
tissue is fully developed, endothelial growth orientation is 
no longer required, thereby evoking the replacement of the 
type-III for type-I collagen, a molecule responsible for the 
tensile strength and mechanical stability of the connective 
tissue (Rich & Whittaker, 2005). Thus, as long as this 
collagen substitutive phenomenon was observed in this 
study, the suitable progression of the healing process was 
attested. 
 Although the replacement of a substantial part of 
the content of type-III collagen for type-I molecules during 
the healing process is an absolutely expected phenomenon 
(Rich & Whittaker, 2005), the excessive production 
of type-I collagen might easily lead to the formation of 
undesirable hypertrofic scars and keloids (Sandulache 
et al., 2007; Verhaegen et al., 2009). On the other hand, 
the moderate content of less thick collagen fibers in AT5 
on 21st day seems to provide low probability of keloid 
development. Besides, the pattern of arrangement and 
balance in the content of both type-I and -III collagen 
fibers as seen in AT5 may suggest that the remodeling 
phase of the scar, represented by degradation of the gross 
connective matrix formed and gradual and progressive 
deposition of a new depurated matrix rich in both collagen 
molecules (Junqueira et al., 1983), is highly advanced 
in comparison to the other groups. These findings could 
justify the clear resemblance with the normal histological 
appearance of the dermal collagen. It must also be stressed 
that since the biological effects of atranorin on fibroplasia 
dynamics seem to be related to a possible increase in the 
fibroblast metabolism, both synthesis and degradation of 
collagen molecules were supposed to be stimulated, as 
observed in this study. Thus, further investigations are 
required in order to fully clarify the precise mechanism of 
the healing modulation pathways provided by this lichenic 
constituent.
 The assessment of CF provided evidences 
that the 5% atranorin ointment might also improve 
the collagen synthesis. Despite the over production of 
collagen may result in hypertrophic scars (Nunes et al., 
2011), this pathological phenomenon was not observed in 
this study. This may suggest that the modulatory effects 
of the atranorin ointment were limited to the middle-
stages of wound healing, not affecting the dynamics of the 
collagen remodeling phase. In addition, the data obtained 
after descriptive and quantitative analysis of the collagen 
content in AT5 seem to be complementary, as long as point 
to a possible role played by atranorin on the fibroblasts 
metabolism.
 Myofibroblasts are a cell type involved 
in wound contraction. These cell subsets present a 
contractile phenotype characterized by a cytoskeleton 
rich in actin microfilaments, and they can be identified by 
immunohistochemistry due to their extensive positivity 
for α-SMA (alpha smooth muscle actin) (Van Beurden et 
al., 2005; Ribeiro et al., 2009). Therefore, myofibroblastic 
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differentiation is supposed to be a crucial event leading 
to a suitable healing of larger wounds, which have more 
extensive loss of cells and tissue (Hinz et al., 2007; Ribeiro 
et al., 2009). In this study, the application of atranorin 
ointment might have provided fibroblastic transformation 
into myofibroblasts at the early stages of the wound 
healing process. Notwithstanding, at 21st day, the number 
of myofibroblasts decreased, most likely due to apoptosis, 
and scar tissue formed. On the other hand, in AT1, the 
healing process appeared to be considerably slower, so 
that the process of myofibroblastic apoptosis apparently 
had not yet taken place. However further studies are 
necessary to clarify if this cell phenotype transformation 
is a direct effect of the atranorin, or a result of the release 
of differentiating factors by other cells involved in the 
healing process.
 It must be emphasized that several of the α-SMA 
positive cells observed in this study were disposed 
surrounding the newly formed blood vessels, and some 
of them appeared to be detaching from the capillaries and 
venules, and they were identified as pericytes (Medrado 
et al., 2010). The participation of pericytes during wound 
healing has already been described, and currently they are 
supposed to work as reserve cells, since their potential to 
differentiate into osteoblasts, chondrocytes, fibroblasts, 
leionyocytes and lipoblasts has been previously studied 
(Farrington-Rocket al., 2004). Despite there is a close 
resemblance in the phenotype of myofibroblasts and 
pericytes, their true relationship and association with the 
healing process is in need of further investigations.
 Surprisingly, the myofibroblasts data provide 
no explanation for the enhanced wound contraction. 
Despite TGF-β-mediated transformation of fibroblasts 
into myofibroblasts is one of the most important 
biological phenomenon related to wound contraction, 
other mechanisms may be involved in this step of the 
healing process, such as superficial topography of wound. 
It is well-established that the mechanical strain exerted 
on collagen fibers orientated in improper angulations, 
generates deleterious internal forces, which induces the 
development of piezoelectric current in the wound site 
(Farahani et al., 2008). On the other hand, the dominance 
of external forces, to the detriment of such damaging 
internal ones, in the wounded milieu seems to provide 
parallel orientation of collagen fibers in relation to the 
skin surface. This external force dominance minimizes 
the induction of such piezoelectricity and up-regulates 
the contractile activity of the previously wounded tissue 
(Farahani & Kloth, 2008). Therefore, it is possible that this 
alternative biological process could have been responsible 
for the wound contraction data observed in this study, but 
further investigations are necessary in order to clarify this 
issue.
 Taken together, the results presented herein 
strongly suggest that atranorin (AT) extracted from 
Cladina kalbii Ahtimodulates the wound healing process 
in the model of excision wounds. Moreover, we can assert 
that atranorin was successful in improving certain steps 
of second-intention wound healing, such as inflammatory 
profile, epithelization and collagen formation. The precise 
mechanisms through which AT exerts its action are 
currently under investigation, but they might be related 
to the arachidonic acid cascade and/or modulation of pro-
inflammatory molecules production.
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